Satellos Bioscience (TSX:MSCL) ROE % Adjusted to Book Value : -45.38% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience ROE % Adjusted to Book Value?

Satellos Bioscience's ROE % for the quarter that ended in Mar. 2024 was -73.52%. Satellos Bioscience's PB Ratio for the quarter that ended in Mar. 2024 was 1.62. Satellos Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -45.38%.

Satellos Bioscience ROE % Adjusted to Book Value Historical Data

The historical data trend for Satellos Bioscience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience ROE % Adjusted to Book Value Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-95.91

-60.10

-60.63

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-21.65	-59.40	-27.96	-50.48	-45.38

Competitive Comparison of Satellos Bioscience's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Satellos Bioscience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's ROE % Adjusted to Book Value falls into.

Satellos Bioscience ROE % Adjusted to Book Value Calculation

Satellos Bioscience's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-72.15%	/	1.19
	=	-60.63%

Satellos Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-73.52%	/	1.62
	=	-45.38%

Satellos Bioscience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines